Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Maintenance × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, B-Cell, Marginal Zone 2 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

X-Rays 4 Specimen Handling 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Nuclear Medicine Department, Hospital 3 Biopsy 3 ulixertinib 2 tazemetostat 2 palbociclib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 LY3023414 2 tipifarnib 1 temsirolimus 1 talazoparib 1 selpercatinib 1 olaparib 1 larotrectinib 1 irinotecan sucrosofate 1 Vincristine 1 Vemurafenib 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiation 1 Proton Therapy 1 Pharmacogenomic Variants 1 Liquid Biopsy 1 Ifosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡